Peripheral T‐ and natural killer‐cell lymphomas: ESMO‐EHA Clinical Practice Guideline for diagnosis, treatment, and follow‐up

HemaSphere, vol. 9, pp. e70128

Abstract

Peripheral T-cell and natural killer (NK)-cell lymphomas (PTCLs) represent a heterogeneous group of neoplasms derived from postthymic T-or NK cells, with diverse morphological patterns, phenotypes, and clinical presentations.The International Consensus Classification and World Health Organization (WHO) classification of lymphoid and hematopoietic neoplasms recognize >30 PTCL entities 1,2 (Supporting Information: Table S1 and Supporting Information Section 1).The incidence and epidemiology of PTCL are described in Supporting Information Section 2. This clinical practice guideline (CPG) covers PTCLs with primary nodal, extranodal, and leukemic presentation.Guidelines for primary cutaneous T-cell lymphomas are reported elsewhere.3

Authors 12

1. Francesco d’Amore

   Aarhus University Hospital

   Affiliation as printed

   Department of Clinical Medicine Aarhus University Hospital Aarhus Denmark

   Department of Haematology Aarhus University Hospital Aarhus Denmark

2. Massimo Federico

   University of Modena and Reggio Emilia

   Affiliation as printed

   CHIMOMO Department University of Modena and Reggio Emilia Emilia‐Romagna Italy

3. Laurence de Leval

   Centre Hospitalier Universitaire Vaudois · University of Lausanne

   Affiliation as printed

   Department of Laboratory Medicine and Pathology Institute of Pathology, Lausanne University Hospital Lausanne University Lausanne Switzerland

4. Fredrik Ellin

   Lund University · Landstinget i Kalmar län

   Affiliation as printed

   Department of Clinical Sciences Lund University Lund Sweden

   Department of Internal Medicine Kalmar County Hospital Kalmar Sweden

5. Olivier Hermine

   Inserm · Université Paris Cité · Assistance Publique – Hôpitaux de Paris · Institut des Maladies Génétiques Imagine

   Affiliation as printed

   Department of Hematology Université de Paris, Assistance Publique‐Hôpitaux de Paris (AP‐HP) Paris France

   Imagine Institute, Hôpital Necker, INSERM U1163 Paris France

6. Won Seog Kim

   Samsung Medical Center · Sungkyunkwan University

   Affiliation as printed

   School of Medicine, Samsung Medical Center Sungkyunkwan University Seoul Korea

7. François Lemonnier

   Inserm · Université Paris-Est Créteil · Assistance Publique – Hôpitaux de Paris · Hôpitaux Universitaires Henri-Mondor · Institut Mondor de Recherche Biomédicale

   Affiliation as printed

   Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, INSERM Créteil France

   Lymphoid Malignancies Unit Hôpital Henri Mondor, Assistance Publique‐Hôpitaux de Paris (AP‐HP) Créteil France

8. Joost S.P. Vermaat Aachen Department of Hematology Leiden University Medical Centre Leiden the Netherlands

   Leiden University · Leiden University Medical Center

   Affiliation as printed

   Department of Hematology Leiden University Medical Centre Leiden The Netherlands

9. Gerald Georg Wulf

   Universitätsmedizin Göttingen · University of Göttingen

   Affiliation as printed

   Department of Hematology and Medical Oncology University Medical Center Göttingen Göttingen Germany

10. Christian Buske
    Affiliation as printed

    Institute of Experimental Cancer Research Ulm Medical University Ulm Sweden

11. Martin H. Dreyling

    Ludwig-Maximilians-Universität München

    Affiliation as printed

    Department of Medicine III Ludwig Maximilian University Munich Germany

12. Mats Jerkeman

    Skåne University Hospital

    Affiliation as printed

    Department of Oncology Skåne University Hospital Lund Sweden